• 1
    IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Tobacco smoke and involuntary smoking. IARC Monogr Eval Carcinog Risks Hum 2004; 83: 11438.
  • 2
    Andersen A, Barlow L, Engeland A, Kjaerheim K, Lynge E, Pukkala E. Work-related cancer in the Nordic countries. Scand J Work Environ Health 1999; 25 ( Suppl 2): 1116.
  • 3
    Pope CA,III, Burnett RT, Thun MJ, Calle EE, Krewski D, Ito K, Thurston GD. Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. JAMA 2002; 287: 113241.
  • 4
    Borm PJ, Schins RP, Albrecht C. Inhaled particles and lung cancer, part B: paradigms and risk assessment. Int J Cancer 2004; 110: 314.
  • 5
    Hecht SS. Biochemistry, biology, and carcinogenicity of tobacco- specificN-nitrosamines. Chem Res Toxicol 1998; 11: 559603.
  • 6
    Kyrtopoulos SA. DNA adducts in humans after exposure to methylating agents. Mutat. Res 1998; 405: 13543.
  • 7
    Hecht SS. Carcinogen biomarkers for lung or oral cancer chemoprevention trials. IARC Sci Publ 2001; 154: 24555.
  • 8
    Hecht SS. Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 1999; 91: 1194210.
  • 9
    Lewis SJ, Cherry NM, Niven RM, Barber PV, Povey AC. Associations between smoking, GST genotypes and N7-methylguanine levels in DNA extracted from bronchial lavage cells. Mutat Res 2004; 559: 1118.
  • 10
    Harrison KL, Khan NS, Dey P, Povey AC. N7-methyldeoxyguanosine levels in DNA isolated from cervical cytology samples are associated with smoking. Int J Cancer 2006; 119: 9613.
  • 11
    Meer L, Janzer RC, Kleihues P, Kolar GF. In vivo metabolism and reaction with DNA of the cytostatic agent, 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (DTIC). Biochem Pharmacol 1986; 35: 32437.
  • 12
    Van BJ, Feron VJ, Leeman WR, Wilmer JW, Vermeulen E, den EL, Scherer E. Immunocytochemical identification of DNA adducts, O6-methylguanine and 7-methylguanine, in respiratory and other tissues of rat, mouse and Syrian hamster exposed to 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Carcinogenesis 1994; 15: 20239.
  • 13
    Chiang SY, Huang TH, Uang SN, Wu HD, Wei YC, Lin HY, Swenberg JA, Wu KY. Analysis of 7-methylguanine using isotope dilution and gas chromatography/electron-capture negative chemical ionization mass spectrometry. Rapid Commun Mass Spectrom 2005; 19: 191520.
  • 14
    Sarangapani R, Teeguarden JG, Gentry PR, Clewell HJ,III, Barton HA, Bogdanffy MS. Interspecies dose extrapolation for inhaled dimethyl sulfate: a PBPK model-based analysis using nasal cavity N7-methylguanine adducts. Inhal Toxicol 2004; 16: 593605.
  • 15
    Ye Z, Song H, Higgins JP, Pharoah P, Danesh J Five glutathione-S-transferase gene variants in 23,452 cases of lung cancer and 30,397 controls: meta-analysis of 130 studies. PLoS Med 2006; 3: e91.
  • 16
    Salama SA, bdel-Rahman SZ, Sierra-Torres CH, Hamada FA, Au WW. Role of polymorphic GSTM1 and GSTT1 genotypes on NNK-induced genotoxicity. Pharmacogenetics 1999; 9: 73543.
  • 17
    Saad AA, O'Connor PJ, Mostafa MH, Metwalli NE, Cooper DP, Margison GP, Povey AC. Bladder tumor contains higher N7-methylguanine levels in DNA than adjacent normal bladder epithelium. Cancer Epidemiol Biomarkers Prev 2006; 15: 7403.
  • 18
    Tew KD. Glutathione-associated enzymes in anticancer drug resistance. Cancer Res 1994; 54: 431320.
  • 19
    Okcu MF, Selvan M, Wang LE, Stout L, Erana R, Airewele G, Adatto P, Hess K, li-Osman F, Groves M, Yung AW, Levin VA, et al. Glutathione-S-transferase polymorphisms and survival in primary malignant glioma. Clin Cancer Res 2004; 10: 261825.
  • 20
    Tetlow N, Robinson A, Mantle T, Board P. Polymorphism of human mu class glutathione transferases. Pharmacogenetics 2004; 14: 35968.
  • 21
    Chu BC, Lawley PD. Increased urinary excretion of nucleic acid and nicotinamide derivatives by rats after treatment with alkylating agents. Chem Biol Interact 1975; 10: 3338.
  • 22
    Shaikh B, Huang SS, Pontzer NJ. Urinary excretion of methylated purines and 1-methyl-nicotinamide following administration of methylating carcinogens. Chem Biol Interact 1980; 30: 2536.
  • 23
    Farmer PB, Shuker EG, Bird I. DNA and protein adducts as indicators of in vivo methylation by nitrosatable drugs. Carcinogenesis 1986; 7: 4952.
  • 24
    Stillwell WG, Xu HX, Adkins JA, Wishnok JS, Tannenbaum SR. Analysis of methylated and oxidized purines in urine by capillary gas chromatography-mass spectrometry. Chem Res Toxicol 1989; 2: 949.
  • 25
    Stillwell WG, Glogowski J, Xu HX, Wishnok JS, Zavala D, Montes G, Correa P, Tannenbaum SR. Urinary excretion of nitrate, N-nitrosoproline, 3-methyladenine, and 7-methylguanine in a Colombian population at high risk for stomach cancer. Cancer Res 1991; 51: 1904.
  • 26
    Ichiba M, Matsumoto A, Kondoh T, Horita M, Tomokuni K. Decreasing urinary PAH metabolites and 7-methylguanine after smoking cessation. Int Arch Occup Environ Health 2006; 79: 5459.
  • 27
    Porcelli B, Muraca LF, Frosi B, Marinello E, Vernillo R, De MA, Catinella S, Traldi P. Fast-atom bombardment mass spectrometry for mapping of endogenous methylated purine bases in urine extracts. Rapid Commun Mass Spectrom 1997; 11: 398404.
  • 28
    Wishnok JS, Tannenbaum SR, Stillwell WG, Glogowski JA, Leaf CD. Urinary markers for exposures to alkylating or nitrosating agents. Environ Health Perspect 1993; 99: 1559.
  • 29
    Sander G, Topp H, Heller-Schoch G, Wieland J, Schoch G. Ribonucleic acid turnover in man:RNA catabolites in urine as measure for the metabolism of each of the three major species of RNA. Clin Sci (Lond) 1986; 71: 36774.
  • 30
    Topp H, Schoch G. Whole-body degradation rates of transfer-, ribosomal-, and messenger ribonucleic acids and resting metabolic rate in 3- to 18-year-old humans. Pediatr Res 2000; 47: 1638.
  • 31
    Davey SG, Ebrahim S. ‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 2003; 32: 122.
  • 32
    Veglia F, Matullo G, Vineis P. Bulky DNA adducts and risk of cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2003; 12: 15760.
  • 33
    Bak H, Autrup H, Thomsen BL, Tjønneland A, Overvad K, Vogel U, Raaschou-Nielsen O, Loft S. Bulky. DNA adducts as risk indicator of lung cancer in a Danish case-cohort study. Int J Cancer 2006; 118: 161822.
  • 34
    Peluso M, Munnia A, Hoek G, Krzyzanowski M, Veglia F, Airoldi L, Autrup H, Dunning A, Garte S, Hainaut P, Malaveille C, Gormally E, et al. DNA adducts and lung cancer risk: a prospective study. Cancer Res 2005; 65: 80428.
  • 35
    Perera FP, Mooney LA, Stampfer M, Phillips DH, Bell DA, Rundle A, Cho S, Tsai WY, Ma J, Blackwood A, Tang D. Associations between carcinogen-DNA damage, glutathione-S-transferase genotypes, and risk of lung cancer in the prospective Physicians' Health Cohort Study. Carcinogenesis 2002; 23: 16416.
  • 36
    Tjønneland A, Overvad OK. Diet, cancer and health–a population study and establishment of a biological bank in Denmark. Ugeskr Laeger 2000; 162: 3504.
  • 37
    Storm HH, Michelsen EV, Clemmensen IH, Pihl J. The Danish Cancer Registry—history, content, quality and use. Dan Med Bull 1997; 44: 5359.
  • 38
    Svoboda P, Kasai H. Simultaneous HPLC analysis of 8-hydroxydeoxyguanosine and 7-methylguanine in urine from humans and rodents. Anal Biochem 2004; 334: 23950.
  • 39
    Sørensen M, Autrup H, Tjonneland A, Overvad K, Raaschou-Nielsen O. Glutathione-S-transferase T1 null-genotype is associated with an increased risk of lung cancer. Int J Cancer 2004; 110: 21924.
  • 40
    Prentice RL. A case-cohort design for epidemiologic cohort studies and disease prevention trails. Biometrika 1986; 73: 111.
  • 41
    Barlow WE, Ichikawa L, Rosner D, Izumi S. Analysis of case-cohort designs. J Clin Epidemiol 1999; 52: 116572.
  • 42
    Barlow WE. Robust variance estimation for the case-cohort design. Biometrics 1994; 50: 106472.
  • 43
    Greenland S. Dose-response and trend analysis in epidemiology: alternatives to categorical analysis. Epidemiology 1995; 6: 35665.
  • 44
    Raaschou-Nielsen O, Thomsen BL, Overvad K, Tjonneland A, Vogel U, Bak H, Autrup H, Loft S. Bulky DNA adducts as risk indicators of lung cancer in a Danish case-cohort study. Int J Cancer 2006; 120: 21213.
  • 45
    Benhamou S, Lee WJ, Alexandrie AK, Boffetta P, Bouchardy C, Butkiewicz D, Brockmoller J, Clapper ML, Daly A, Dolzan V, Ford J, Gaspari L, et al. Meta- and pooled analyses of the effects of glutathione-S-transferase M1 polymorphisms and smoking on lung cancer risk. Carcinogenesis 2002; 23: 134350.
  • 46
    Gray N The consequences of the unregulated cigarette. Tob Control 2006; 15: 4058.
  • 47
    Devesa SS, Bray F, Vizcaino AP, Parkin DM International lung cancer trends by histologic type: male:female differences diminishing and adenocarcinoma rates rising. Int J Cancer 2005; 117: 2949.
  • 48
    Le Marchand L, Sivaraman L, Pierce L, Seifried A, Lum A, Wilkens LR, Lau AF. Associations of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens. Cancer Res 1998; 58: 485863.
  • 49
    Wang H, Tan W, Hao B, Miao X, Zhou G, He F, Lin D. Substantial reduction in risk of lung adenocarcinoma associated with genetic polymorphism in CYP2A13, the most active cytochrome P450 for the metabolic activation of tobacco-specific carcinogen NNK. Cancer Res 2003; 63: 805761.
  • 50
    Cohet C, Borel S, Nyberg F, Mukeria A, Bruske-Hohlfeld I, Constantinescu V, Benhamou S, Brennan P, Hall J, Boffetta P. Exon 5 polymorphisms in the O6-alkylguanine DNA alkyltransferase gene and lung cancer risk in non-smokers exposed to second-hand smoke. Cancer Epidemiol Biomarkers Prev 2004; 13: 3203.
  • 51
    Fujieda M, Yamazaki H, Saito T, Kiyotani K, Gyamfi MA, Sakurai M, aka-Akita H, Sawamura Y, Yokota J, Kunitoh H, Kamataki T. Evaluation of CYP2A6 genetic polymorphisms as determinants of smoking behavior and tobacco-related lung cancer risk in male Japanese smokers. Carcinogenesis 2004; 25: 24518.
  • 52
    Wang L, Liu H, Zhang Z, Spitz MR, Wei Q. Association of genetic variants of O6-methylguanine-DNA methyltransferase with risk of lung cancer in non-Hispanic Whites. Cancer Epidemiol Biomarkers Prev 2006; 15: 23649.
  • 53
    La TG, Boccia S, Ricciardi G. Glutathione-S-transferase M1 status and gastric cancer risk: a meta-analysis. Cancer Lett 2005; 217: 5360.
  • 54
    Starratt AN, Bond EJ. Methylation of DNA of maize and wheat grains during fumigation with methyl-bromide. J Agric Food Chem 1988; 36: 10359.
  • 55
    Prevost V, Shuker DE, Bartsch H, Pastorelli R, Stillwell WG, Trudel LJ, Tannenbaum SR. The determination of urinary 3-methyladenine by immunoaffinity chromatography-monoclonal antibody-based ELISA: use in human biomonitoring studies. Carcinogenesis 1990; 11: 174751.